Similar articles

• Placebo controls are not good science.

  Weijer C, Appelbaum P. Weijer C, et al. IRB. 1996 Sep-Oct;18(5):8-10. IRB. 1996. PMID: 11654741 No abstract available.
• Response to "Ethical concerns about relapse studies" by Adil E. Shamoo and Timothy J. Keay (CQ Vol 5, No 3). Research with vulnerable subjects.

  Bergsma J. Bergsma J. Camb Q Healthc Ethics. 1997 Spring;6(2):233-4. Camb Q Healthc Ethics. 1997. PMID: 9179416 No abstract available.
• Dilemmas in the use of active control groups in clinical research.

  Makuch RW, Johnson MF. Makuch RW, et al. IRB. 1989 Jan-Feb;11(1):1-5. IRB. 1989. PMID: 11659084 No abstract available.
• Toward an informed discussion of informed consent: a review and critique of the empirical studies.

  Meisel A, Roth LH. Meisel A, et al. Ariz Law Rev. 1983;25(2):265-346. Ariz Law Rev. 1983. PMID: 11658677 Review. No abstract available.
• [Methodologic problems of clinical investigations of antidepressants].

  Puzyński S. Puzyński S. Psychiatr Pol. 2005 May-Jun;39(3):435-47. Psychiatr Pol. 2005. PMID: 16149754 Review. Polish.